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Abstract
Abstract Secondhand smoke (SHS) exposure has negative effects on maternal and infant health. 
SHS exposure among pregnant women in Argentina and Uruguay has not been previously 
described, nor has the proportion of those who have received screening and advice to avoid SHS 
during prenatal care. Women who attended one of 21 clusters of publicly-funded prenatal care 
clinics were interviewed regarding SHS exposure during pregnancy at their delivery 
hospitalization during 2011–2012. Analyses were conducted using SURVEYFREQ procedure in 
SAS version 9.3 to account for prenatal clinic clusters. Of 3,427 pregnant women, 43.4 % had a 
partner who smoked, 52.3 % lived with household members who smoked cigarettes, and 34.4 % 
had no or partial smoke-free home rule. Of 528 pregnant women who worked outside of the home, 
21.6 % reported past month SHS exposure at work and 38.1 % reported no or partial smoke-free 
work policy. Overall, 35.9 % of women were exposed to SHS at home or work. In at least one 
prenatal care visit, 67.2 % of women were screened for SHS exposure, and 56.6 % received advice 
to avoid SHS. Also, 52.6 % of women always avoided SHS for their unborn baby's health. In 
summary, a third of pregnant women attending publicly-funded prenatal clinics were exposed to 
SHS, and only half of pregnant women always avoided SHS for their unborn baby's health. 
Provider screening and advice rates can be improved in these prenatal care settings, as all pregnant 
women should be screened and advised of the harms of SHS and how to avoid it.
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Exposure to secondhand smoke (SHS) has negative effects on maternal and infant health [1]. 
Pregnant women who are exposed to SHS have 20 % higher odds of giving birth to a low 
birth weight infant compared to women who are not exposed [2]. A meta-analysis of 76 
studies found mothers exposed to SHS have small but significantly increased risks of having 
a lower birth weight infant (60 g difference) than those not exposed and an increased risk of 
congenital anomalies (OR 1.17; 95 % CI 1.03–1.34) [3]. Furthermore, infants who are 
exposed to SHS are more likely to die of sudden infant death syndrome (SIDS) compared 
with infants not exposed, and children exposed to SHS are at increased risk for bronchitis, 
pneumonia, ear infections, more severe asthma, respiratory symptoms, and slowed lung 
growth [1]. Thus, preventing SHS exposure during pregnancy could avert poor pregnancy, 
infant, and child health outcomes.
Globally, 40 % of children and 35 % of female non-smokers were exposed to SHS in 2004 
[4]. In 2002, Argentina and Uruguay had the highest median concentration of airborne 
nicotine, a measure of SHS, in most public places of their capital cities compared to other 
Latin American capitals in Brazil, Chile, Costa Rica, Paraguay, and Peru [5]. Significantly 
more men than women smoke cigarettes in Argentina (32 vs 22 %) and Uruguay (30 vs 20 
%) [6]. Thus, SHS exposure in households with non-smokers, such as spouses, partners, and 
children who do not smoke, should be considered. Understanding the burden of SHS 
exposure may help ministries of health direct appropriate resources to address the problem. 
Previous studies have reported SHS exposure among women and children in these countries 
using biochemical measures [7] and self-report [8]. However, the proportion of pregnant 
women exposed to SHS and sources of these exposures have not been previously estimated 
in these countries. In 2013, the World Health Organization (WHO) released guidelines 
recommending that antenatal care providers screen all pregnant women for SHS exposure 
and provide brief advice on the harms of SHS [9]. To our knowledge, it is not known to 
what extent providers screen for and provide brief advice on SHS exposure in Argentina and 
Uruguay. It is also unknown how frequently pregnant women avoid SHS to protect their 
unborn baby's health.
The study objectives were to estimate the prevalence of pregnant women who were exposed 
to SHS, identify the sources of their exposure, and describe the characteristics of those 
exposed to SHS by women's smoking status. We also sought to estimate the prevalence of 
pregnant women who were screened for SHS exposure and were advised of the harms of 
SHS during prenatal care. Because advice could vary based on whether pregnant women 
smoked, we examined SHS exposure and receipt of services by smoking status. These study 
results may be used to inform tobacco control efforts and antenatal care practices in 
Argentina and Uruguay.
Methods
Data were collected at baseline as part of a cluster randomized-controlled trial and prior to 
implementing a brief smoking cessation counseling intervention in prenatal clinics. Detailed 
methodology of the trial is published elsewhere [10]. Trained interviewers identified 
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consecutively eligible women during their postpartum stay to determine who attended one of 
21 clusters of prenatal care clinics and delivered a baby in any of ten public hospitals in 
Buenos Aires, Argentina or two public hospitals in Montevideo, Uruguay, from October 
2011 to May 2012. Consented women were surveyed using a validated questionnaire about 
tobacco use and SHS exposure during pregnancy and whether they received provider 
screening and advice on SHS exposure during prenatal care. The study was approved by the 
ethics committees/institutional review boards of all participating hospitals; the Ministry of 
Health of the Province of Buenos Aires, Argentina; the Centro de Educación Médica e 
Investigaciones Clínicas “Norberto Quirno”; the Faculty of Medicine, Universidad de la 
República, Uruguay; Centers for Disease Control and Prevention; and Tulane University.
Variables
SHS exposure during pregnancy was determined from questions to each woman on whether 
her partner or other household members smoked cigarettes, whether smoking was allowed in 
her home, whether anyone at work smoked in the last 30 days, whether smoking was 
allowed at her workplace, and how often she was indoors and around other people who were 
smoking. Composite measures were created of SHS exposure during pregnancy at home, at 
work, and at home or work. SHS exposure at home was defined from a woman's report 
about (1) whether smoking was allowed in her home or on certain occasions or in certain 
rooms and (2) whether a partner or other household member who lived with her smoked. 
SHS exposure at work was defined from a woman's report about whether anyone at work 
smoked indoors in the last 30 days.
All women were asked if they received provider screening for SHS exposure. Women were 
also asked about whether their prenatal care providers advised about the harms of SHS to 
themselves or to their unborn infant. Composite measures were created of receipt of 
screening for SHS exposure at home or work, and receipt of advice of harm of SHS to 
women or unborn infants. These measures were assessed for any and all prenatal care visits. 
Women were also asked how often they tried to avoid breathing SHS because they thought it 
was bad for the health of their unborn baby. Response options included: never, rarely, 
sometimes, and always.
Women's smoking status was categorized as nonsmokers or smokers. Nonsmokers were 
those who reported never smoking, tried cigarettes but did not smoke regularly, or quit 
smoking before they found out that they were pregnant. Smokers were those who smoked 
every day or some days before they found out they were pregnant and included women who 
quit smoking sometime during pregnancy and those who continued to smoke during 
pregnancy. Women who self-reported quitting smoking during pregnancy provided saliva 
samples within 12 h after delivery so that cotinine testing could confirm their quit status.
Additional variables derived from women's interviews and included in the analysis were 
maternal age, foreign citizenship, marital status, highest level of education completed, work 
status in past year, and trimester that prenatal care was initiated. Parity was derived from the 
clinical record.
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A total of 3,427 were included in the sample. Of these, 1,880 women (54.9 %) gave birth in 
Argentina and 1,547 women (45.1 %) in Uruguay. Differences in characteristics of SHS 
exposure, receipt of prenatal care provider screening, advice regarding SHS exposure, and 
avoidance of SHS during pregnancy by smoking status was assessed using the Wald Chi 
square test for homogeneity of proportions (significance was set at P < 0.05). As no 
statistical differences in SHS exposure were observed by country, the data were presented in 
aggregate. Sample size varied by variable. As the proportion of missing data was small in 
our study [SHS variables: ranging from 0.6 % (smoke-free home rules) to 5.5 % (partner 
smokes) and smoking status (4.2 %)] such that bias in any parameter estimates when 
compared to complete data is likely to be small [11]. Analyses were conducted using the 
SURVEYFREQ procedure in SAS version 9.3 to account for prenatal clinic care clusters 
(SAS Institute, Inc., Cary, NC).
Results
Of 3,427 pregnant women, most were aged 20–34 years (70.6 %), were citizens of 
Argentina or Uruguay (93.3 %), were married or partnered (85.4 %), were unemployed in 
the past year (76.4 %), were multiparous (65.5 %), and had initiated prenatal care in the first 
trimester (52.3 %) (Table 1). Almost half of women (46.2 %) had an incomplete secondary 
education. The majority of women in the sample were nonsmokers (69.8 %). Compared to 
smokers, nonsmokers were more likely to be of foreign citizenship, be married or partnered, 
have higher education, and be nulliparous (P < 0.05). No differences were observed between 
smokers and nonsmokers by maternal age, employment status, and initiation of prenatal 
care.
Overall, 43.4 % of pregnant women had a partner who smoked, 52.3 % had smokers living 
in the household, and 34.4 % reported having no or a partial smoke-free rule in the home 
(Table 2). Among pregnant women who worked outside of the home (n = 528, 18.2 % of the 
total sample), 21.6 % were exposed to smoke at work in the past month, and 38.1 % had no 
or a partial smoke-free policy at work. Sixteen percent of women reported being always 
exposed to SHS at home, work, or public places. Overall, 34.1 % of pregnant women were 
exposed to SHS at home, 19.9 % of pregnant women who worked outside of the home were 
exposed to SHS at work, and 35.9 % percent were exposed at home or work (Fig. 1).
Compared to smokers, nonsmokers were more likely to report having a 100 % smoke-free 
rule at home, having nonsmoking partners, living with nonsmokers in their household, and 
never being around other smokers at home, work, and public places (Table 2). There were 
also differences by smoking status among working women exposed to SHS at work in the 
past month. When examining characteristics of nonsmokers who were exposed to SHS at 
home, compared to those not exposed, a higher proportion of nonsmokers exposed to SHS at 
home were aged ≤19 years (23.8, 14.4 %) and nulliparous (45.1, 32.4 %) (data not shown).
In at least one prenatal visit, the majority of women (65.9 %) were asked by their prenatal 
care provider about SHS exposure at home, 26.8 % were asked about SHS exposure at work, 
and 67.2 % were asked about SHS exposure at home or work (Table 3). A lower percentage 
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of women were asked about SHS at home (10.5 %), at work (4.2 %), or at home or work 
(11.1 %) at all prenatal care visits. Half of pregnant women were advised that SHS was not 
good for their health (53.7 %) or their baby's health (51.2 %) in at least one visit. About 56.6 
% were advised that SHS was not good for her or her baby's health in at least one visit.
There were differences between smokers and nonsmokers on whether their provider asked 
about SHS exposure at work in any prenatal care visits, but smokers were more likely to be 
asked about SHS at home or work in all visits (Table 3). Smokers were more likely to be 
advised about the harms of SHS exposure at any visit or in all visits compared to 
nonsmokers. Among the 35.9 % of women (n = 1,231) who were exposed to SHS, 59.8 % 
received provider advice to avoid SHS.
Approximately 52.6 % of women reported they always avoided SHS during pregnancy 
because of concerns about their babies’ health (data not shown). Nonsmokers were 
significantly more likely to always avoid SHS for their babies’ health compared to smokers 
(63.5, 28.6 %).
Discussion
Overall, 67.2 % of women reported being screened for SHS exposure either at home or in 
the workplace and 56.6 % reported receiving advice to avoid SHS during prenatal care. We 
found that one-third of pregnant women reported exposure to SHS at home or at work, with 
the majority exposed to SHS at home by their partner or other household members who 
smoked. Yet, little more than half of these women reported receiving any information from 
their prenatal care provider on the harms of SHS to themselves or their babies. Furthermore, 
only half of pregnant women (52.6 %) reported that they always avoided SHS because of 
concerns about their babies’ health.
The percentages (67.2 and 56.6 %) of screening and brief advice for SHS in our study are 
lower than the WHO recommendation that during antenatal care visits all pregnant women 
be routinely screened and provided brief advice on the harms of SHS exposure [9]. Best 
practices for treatment of tobacco dependence during pregnancy have focused on screening 
for active maternal smoking and providing assistance to pregnant smokers who want to quit 
[12, 13] but screening and advice on SHS exposure have not been recommended broadly for 
both smokers and nonsmokers during pregnancy. National guidelines, clinical protocols, and 
training can support the goal that during prenatal care all pregnant women be informed of 
the harms of SHS and advised to avoid it [14, 15].
Beyond brief advice to avoid harms of SHS, it is unknown whether additional provider 
intervention, such as counseling women to avoid SHS and providing assistance to partners 
to quit smoking, may be more effective in eliminating SHS exposure during pregnancy. 
There have been a limited number of studies that have evaluated interventions to reduce 
SHS among nonsmoking pregnant women, and though some reported positive effects on 
reducing SHS, the majority of studies are based on self-reported SHS exposure, which may 
be unreliable [16]. Thus, additional trials are needed that biochemically verify intervention 
effect of reducing SHS exposure at the end of pregnancy.
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For all measures of SHS exposure at home and at work, smokers were more likely to be 
exposed to SHS than nonsmokers, and smokers were significantly more likely to receive 
advice about the harms of SHS than nonsmokers. As noted earlier, national clinical 
guidelines exist in Argentina and Uruguay that promote intervention with pregnant smokers 
and, often, SHS exposure is addressed to protect the health of infants. Given that four out of 
ten nonsmokers in our study lived in households that included smokers, more attention is 
needed to ensure that routine screening and advice occur for all pregnant women regardless 
of smoking status.
We found that 65.6 % of women reported that they had a smoke-free rule in their home 
during pregnancy. Nonsmokers most likely to be exposed to SHS at home were young, first-
time mothers. Increased implementation of voluntary smoke-free home rules can be 
achieved through educating pregnant women and their families, and may be encouraged by 
the adoption of smoke-free policies in worksites and public places [17]. As public settings 
increasingly become smoke-free, awareness of the harms of SHS becomes more prevalent in 
communities, which can encourage changes in the social environment and increase the 
unacceptability of smoking indoors [1]. In addition to their effectiveness in reducing 
smoking prevalence among the general population, public smoke-free policies may also 
reduce SHS exposure among pregnant nonsmokers [18, 19] and reduce smoking among 
pregnant smokers [20–22], thereby improving birth outcomes. In 2006, Uruguay was the 
first country in the Americas to pass comprehensive national smoke-free legislation [23]. In 
2011, Argentina passed legislation to prohibit smoking in public places. Thus, to target 
young pregnant women and those who live with them, including families and partners, 
educational materials in these countries can be developed with simple health messages about 
the harms of SHS and the importance of smoke-free homes.
This is the first study to assess prenatal provider practices regarding screening and brief 
advice for SHS exposure during pregnancy in two Latin America countries using the new 
WHO recommendations. Given the high and increasing rates of smoking in this region and 
potential for SHS exposure [4], these findings can be used to improve obstetrical practice 
and inform the development of educational materials to eliminate SHS exposure in pregnant 
women. Second, the study used validated and standardized questions to assess SHS 
exposure; thus allowing our data to be compared with SHS data from other countries and 
settings [24].
This study is not without limitations. First, smoke-free home status and whether smokers 
lived with the pregnant woman were self-reported by women at delivery, and there was no 
biochemical verification of SHS exposure. Recall and nondisclosure bias could result in 
underre-porting of SHS exposure, but it is unknown the degree to which underreporting 
occurs among pregnant women in these countries. However, a Japanese study found that 
pregnant women's reports of smoking among partners and other household members 
correlated with cotinine levels to indicate the woman's SHS exposure [25]. In the current 
study, both women's reports of partner smoking and other household smokers were used to 
indicate exposure at home. Second, women were asked whether co-workers smoked indoors 
to assess workplace SHS exposure, but we were unable to assess the proximity to which the 
co-workers smoked near them. SHS can infiltrate many areas of a building or home even 
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with designated smoking areas [26, 27], thus indicating any smoking indoors may result in 
exposure. Finally, these findings may not be general-izable beyond the study participants in 
these two countries.
In conclusion a third of pregnant women attending public prenatal clinics in Buenos Aires 
and Montevideo are exposed to SHS, predominantly at home. Because pregnancy may be an 
opportune time to make positive behavior change, such as avoiding SHS exposure, more 
work is needed in these countries to encourage prenatal care providers to screen all pregnant 
women for SHS exposure, to promote smoke-free home environments, and to counsel 
women to always avoid SHS exposure. Whenever possible, providers can encourage 
partners and family members to quit smoking to protect the health of pregnant women and 
their babies. Further research is needed to identify interventions beyond brief advice which 
may be effective for eliminating SHS exposure during pregnancy.
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N % (95 % CI) N % N %
Total 3,427 100 2,292 69.8 991 30.2
Age (years)
    ≤19 581 17.2 (15.0–19.4) 398 17.6 159 16.3 0.5241
    20–34 2,390 70.6 (68.2–73.1) 1,584 69.9 706 72.2
    ≥35 412 12.2 (10.7–13.6) 284 12.5 113 11.5
Foreign citizenship
    Yes 228 6.7 (3.8–9.6) 202 8.9 20 2.0 0.0010
    No 3,173 93.3 (90.4–96.2) 2,073 91.1 966 98.0
Marital status
    Married or partnered 2,896 85.4 (82.7–88.1) 1,976 87.0 764 82.2 0.0018
    Unmarried 494 14.6 (11.9–17.3) 295 13.0 129 17.8
Highest level of education
    Incomplete primary school or less 220 6.4 (4.4–8.5) 150 6.6 64 6.5 0.0002
    Completed primary school 939 27.6 (23.1–32.1) 586 25.7 328 33.2
    Incomplete secondary school 1,571 46.2 (39.4–52.9) 1,025 45.0 465 47.1
    Completed secondary or more 673 19.8 (13.0–26.6) 515 22.6 131 13.2
Work status in past year
    Employed or student 780 23.6 (17.8–29.4) 507 22.9 234 24.3 0.5499
    Unemployed 2,530 76.4 (70.6–82.2) 1,706 77.1 727 75.7
Parity
    0 1,118 34.5 (31.4–37.7) 790 36.5 282 29.9 0.0050
    ≥1 2,118 65.5 (62.3–68.6) 1,375 63.5 602 70.1
Initiation of prenatal care
    First trimester 1,676 52.3 (45.8–58.7) 1,126 52.4 480 51.8 0.7431
    Second trimester 1,269 39.5 (34.9–44.2) 840 39.1 377 40.7
    Third trimester 262 8.2 (5.4–10.7) 183 8.5 70 7.5
CI confidence intervals
a
Sample size varied by each item due to missing values, ranging from 0.7 % (education) to 6.4 % (initiation of prenatal care)
b
Smoking status was missing for 144 women (4.2 %)
c
Chi square tests were used to assess differences between nonsmokers and smokers
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Table 2








N % (95 % CI) N % N %
Smoke-free home rule
    Yes 2,236 65.6 (61.5–69.8) 1,667 73.0 485 48.2 <.0001
    No 1,170 34.4 (30.2–38.5) 617 27.0 501 50.8
Partner smokes
    Yes 1,407 43.4 (41.1–45.8) 743 34.1 589 63.5 <.0001
    No 1,832 56.6 (54.2–58.9) 1,438 65.9 338 36.5
Number of smokers in household
d
    None 1,634 47.7 (44.2–51.2) 1,288 56.2 293 29.6 <.0001
    1 1,188 38.9 (36.1–11.7) 755 32.9 514 51.9
    2 299 8.7 (7.5–10.0) 169 7.4 113 11.4
    3+ 161 4.5 (3.8–5.6) 80 3.5 71 7.2
Smoke-free workplace policy
e
    Yes 327 61.9 (57.4–66.4) 240 64.3 87 56.1 0.1858
    No 201 38.1 (33.6–42.6) 133 35.7 68 43.9
Exposure to smoke at work in the last 30 days
e
    Yes 105 21.6 (16.9–26.2) 67 19.5 38 26.4 0.0343
    No 382 78.4 (73.8–83.1) 276 80.5 106 73.6
How often around smokers (home, work, public places)
    Never 788 23.7 (16.9–30.5) 627 28.2 142 14.7 0.0001
    Rarely 903 27.2 (21.0–33.3) 710 31.9 153 15.9
    Sometimes 1,102 33.1 (30.4–35.9) 655 29.4 385 40.0
    Always 534 16.1 (13.6–18.5) 235 10.6 283 29.4
CI confidence interval
a
Sample size varied by each item due to missing values, ranging from 0.6 % (smoke-free home rule) to 5.5 % (partner smokes)
b
Smoking status was missing for 144 women (4.2 %)
c
Chi square tests were used to assess differences between nonsmokers and smokers
d
Excludes the pregnant smoker
e
Exposure to smoke at work was calculated only among women who reported working outside of the house (n = 528)
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Table 3
Prevalence of providers' asking about secondhand smoke (SHS) exposure and advising about adverse health 







N % (95% CI) N % N % (95 % CI)
b
At least one visit
Ask
    Provider asked about SHS exposure at home 2,235 65.9 (55.5–76.3) 1,478 65.1 673 68.6 –0.04 (–0.09, 0.02) 0.2161
    Provider asked about SHS exposure at work 868 26.8 (18.7–34.8) 551 25.2 291 31.6 –0.06 (–0.11, –0.02) 0.0107
    Provider asked about SHS exposure at home 
or work
2,257 67.2 (56.7–77.7) 1,494 66.2 678 70.3 –0.04 (–0.10, 0.02) 0.1549
Advise
    Provider advised women that SHS was not 
good for their health
1,821 53.7 (43.6–63.8) 1,107 48.7 632 64.4 –0.16 (–0.20, –0.12) <.0001
    Provider advised women that SHS was not 
good for their babieś health
1,737 51.2 (40.6–61.7) 1,065 46.8 594 60.5 –0.14 (–0.18, –0.09) <.0001
    Provider advised women that SHS was not 
for their health or their babies' health
1,923 56.6 (46.5–66.8) 1,181 51.9 657 66.8 –0.15 (–0.20, –0.10) <.0001
In all prenatal visits
Ask
    Provider asked about SHS exposure at home 354 10.5 (5.2–15.7) 196 8.6 145 14.8 –0.06 (–0.11, –0.02) 0.0151
    Provider asked about SHS exposure at work 136 4.2 (1.6–6.8) 77 3.5 56 6.1 –0.03 (–0.05, –0.00) 0.0313
    Provider asked about SHS exposure at home 
or work
361 11.1 (5.4–16.8) 200 9.1 147 15.9 –0.07 (–0.12, –0.02) 0.0154
Advise
    Provider advised women that SHS was not 
good for their health
294 8.7 (4.3–13.0) 140 6.2 141 14.4 –0.08 (–0.13, –0.04) 0.0044
    Provider advised women that SHS was not 
good for their babieś health
275 8.1 (4.1–12.2) 128 5.6 134 13.7 –0.08 (–0.12, –0.04) 0.0032
    Provider advised women that SHS was not 
for their health or their babies' health
320 9.5 (5.0–14.0) 153 6.7 152 15.6 –0.09 (–0.13, –0.04) 0.0023
SHS secondhand smoke, CI confidence interval
a
Smoking status was missing for 144 women (4.2 %)
b
Difference in prevalence between nonsmokers and smokers
c
Chi square tests were used to assess differences between nonsmokers and smokers
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